Gene expression analysis in breast cancer. A new diagnostic tool in pathology

被引:0
作者
Denkert, C. [1 ]
机构
[1] Charite, Inst Pathol, D-10117 Berlin, Germany
来源
PATHOLOGE | 2013年 / 34卷 / 05期
关键词
Molecular biomarkers; Prognosis; Chemotherapy; Molecular diagnostics; EndoPredict; CLINICAL-ONCOLOGY-COLLEGE; PARAFFIN-EMBEDDED TISSUE; GUIDELINE RECOMMENDATIONS; ESTROGEN-RECEPTOR; AMERICAN-SOCIETY; ANALYTICAL VALIDATION; HER2; STATUS; RECURRENCE; PROGNOSIS; RNA;
D O I
10.1007/s00292-013-1781-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Molecular biomarker analysis is increasingly being used as a basis for individualized therapy selection. In breast cancer established standard biomarkers are hormone receptors, HER2 and if indicated Ki67. In particular for hormone receptor positive, HER2 negative tumors, gene expression analysis provides additional information on proliferation and hormone receptor signalling. The results of the gene expression tests can be used to identify patients with a very good prognosis under an exclusive endocrine therapy. This group of patients can then be treated without conventional chemotherapy. The EndoPredict assay was validated in two large cohorts from clinical studies of the Austrian breast cancer study group (ABCSG). Furthermore, using a round robin test, the test method was established in several German institutes of molecular pathology. The EndoPredict assay can be carried out in local institutes of pathology and offers additional information to existing standard prognostic parameters.
引用
收藏
页码:413 / 418
页数:6
相关论文
共 28 条
[1]   Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement [J].
Azim, H. A., Jr. ;
Michiels, S. ;
Zagouri, F. ;
Delaloge, S. ;
Filipits, M. ;
Namer, M. ;
Neven, P. ;
Symmans, W. F. ;
Thompson, A. ;
Andre, F. ;
Loi, S. ;
Swanton, C. .
ANNALS OF ONCOLOGY, 2013, 24 (03) :647-654
[2]   PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers [J].
Bastien, Roy R. L. ;
Rodriguez-Lescure, Alvaro ;
Ebbert, Mark T. W. ;
Prat, Aleix ;
Munarriz, Blanca ;
Rowe, Leslie ;
Miller, Patricia ;
Ruiz-Borrego, Manuel ;
Anderson, Daniel ;
Lyons, Bradley ;
Alvarez, Isabel ;
Dowell, Tracy ;
Wall, David ;
Angel Segui, Miguel ;
Barley, Lee ;
Boucher, Kenneth M. ;
Alba, Emilio ;
Pappas, Lisa ;
Davis, Carole A. ;
Aranda, Ignacio ;
Fauron, Christiane ;
Stijleman, Inge J. ;
Palacios, Jose ;
Anton, Antonio ;
Carrasco, Eva ;
Caballero, Rosalia ;
Ellis, Matthew J. ;
Nielsen, Torsten O. ;
Perou, Charles M. ;
Astill, Mark ;
Bernard, Philip S. ;
Martin, Miguel .
BMC MEDICAL GENOMICS, 2012, 5
[3]   RNA Extraction from Archival Formalin-Fixed Paraffin-Embedded Tissue: A Comparison of Manual, Semiautomated, and Fully Automated Purification Methods [J].
Bohmann, Kerstin ;
Hennig, Guido ;
Rogel, Uwe ;
Poremba, Christopher ;
Mueller, Berit Maria ;
Fritz, Peter ;
Stoerkel, Stephan ;
Schaefer, Karl-L. .
CLINICAL CHEMISTRY, 2009, 55 (09) :1719-1727
[4]   Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer [J].
Cheang, Maggie C. U. ;
Chia, Stephen K. ;
Voduc, David ;
Gao, Dongxia ;
Leung, Samuel ;
Snider, Jacqueline ;
Watson, Mark ;
Davies, Sherri ;
Bernard, Philip S. ;
Parker, Joel S. ;
Perou, Charles M. ;
Ellis, Matthew J. ;
Nielsen, Torsten O. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10) :736-750
[5]   Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer [J].
Cronin, Maureen ;
Sangli, Chithra ;
Liu, Mei-Lan ;
Pho, Mylan ;
Dutta, Debjani ;
Nguyen, Anhthu ;
Jeong, Jennie ;
Wu, Jenny ;
Langone, Kim Clark ;
Watson, Drew .
CLINICAL CHEMISTRY, 2007, 53 (06) :1084-1091
[6]   RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy [J].
Denkert, C. ;
Loibl, S. ;
Kronenwett, R. ;
Budczies, J. ;
von Toerne, C. ;
Nekljudova, V. ;
Darb-Esfahani, S. ;
Solbach, C. ;
Sinn, B. V. ;
Petry, C. ;
Mueller, B. M. ;
Hilfrich, J. ;
Altmann, G. ;
Staebler, A. ;
Roth, C. ;
Ataseven, B. ;
Kirchner, T. ;
Dietel, M. ;
Untch, M. ;
von Minckwitz, G. .
ANNALS OF ONCOLOGY, 2013, 24 (03) :632-639
[7]   Decentral gene expression analysis for ER+/Her2-breast cancer: results of a proficiency testing program for the EndoPredict assay [J].
Denkert, Carsten ;
Kronenwett, Ralf ;
Schlake, Werner ;
Bohmann, Kerstin ;
Penzel, Roland ;
Weber, Karsten E. ;
Hoefler, Heinz ;
Lehmann, Ulrich ;
Schirmacher, Peter ;
Specht, Katja ;
Rudas, Margaretha ;
Kreipe, Hans-Heinrich ;
Schraml, Peter ;
Schlake, Gudrun ;
Bago-Horvath, Zsuzsanna ;
Tiecke, Frank ;
Varga, Zsuzsanna ;
Moch, Holger ;
Schmidt, Marcus ;
Prinzler, Judith ;
Kerjaschki, Dontscho ;
Sinn, Bruno Valentin ;
Mueller, Berit Maria ;
Filipits, Martin ;
Petry, Christoph ;
Dietel, Manfred .
VIRCHOWS ARCHIV, 2012, 460 (03) :251-259
[8]   Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group [J].
Dowsett, Mitch ;
Nielsen, Torsten O. ;
A'Hern, Roger ;
Bartlett, John ;
Coombes, R. Charles ;
Cuzick, Jack ;
Ellis, Matthew ;
Henry, N. Lynn ;
Hugh, Judith C. ;
Lively, Tracy ;
McShane, Lisa ;
Paik, Soon ;
Penault-Llorca, Frederique ;
Prudkin, Ljudmila ;
Regan, Meredith ;
Salter, Janine ;
Sotiriou, Christos ;
Smith, Ian E. ;
Viale, Giuseppe ;
Zujewski, Jo Anne ;
Hayes, Daniel F. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (22) :1656-1664
[9]   EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer [J].
Dubsky, P. ;
Filipits, M. ;
Jakesz, R. ;
Rudas, M. ;
Singer, C. F. ;
Greil, R. ;
Dietze, O. ;
Luisser, I. ;
Klug, E. ;
Sedivy, R. ;
Bachner, M. ;
Mayr, D. ;
Schmidt, M. ;
Gehrmann, M. C. ;
Petry, C. ;
Weber, K. E. ;
Kronenwett, R. ;
Brase, J. C. ;
Gnant, M. .
ANNALS OF ONCOLOGY, 2013, 24 (03) :640-647
[10]  
DUBSKY P, 2012 SAN ANT BREAST